Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,723,248
+$992,898 QoQ
Shares Held
10,822
+36.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#1,717
of 4,153 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026S-Bank Fund Management Ltd holds $36,501,541 across 9 Drug Manufacturers - General names. ABBV ranks #4 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,834 | $18,991,776 | |
| 2 | JNJ |
Johnson & Johnson
|
22,884 | $5,811,849 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,426 | $3,909,741 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
10,822 | $2,723,248 | |
| 5 | AMGN |
Amgen Inc
|
4,000 | $1,448,480 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,870 | $1,373,315 | |
| 7 | PFE |
Pfizer Inc
|
39,521 | $951,665 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
15,694 | $904,288 |
All Filings in ABBV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,723,248 | 10,822 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,730,350 | 7,956 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,885,499 | 8,252 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,940,558 | 12,700 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $2,388,186 | 12,866 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $2,830,615 | 13,510 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||